Selected research
Industry Research
Veterinary Anthrax Vaccines Industry Research Report 2026
Market perspective
The global Veterinary Anthrax Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary Anthrax Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary Anthrax Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary Anthrax Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary Anthrax Vaccines include JOVAC, Intervac (PVT) Ltd, Institute for Biological Products, Indian Immunologicals Limited, Empresa Colombiana de Productos Veterinarios S.A, Colorado Serum Company, Ceva Sante Animale, Centro Diagnostico Veterinario and Central Veterinary Control and Research Institute, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Anthrax Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary Anthrax Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Anthrax Vaccines Market by Company
JOVAC
Intervac (PVT) Ltd
Institute for Biological Products
Indian Immunologicals Limited
Empresa Colombiana de Productos Veterinarios S.A
Colorado Serum Company
Ceva Sante Animale
Centro Diagnostico Veterinario
Central Veterinary Control and Research Institute
Botswana Vaccine Institute
Biogenesis Bago SA
Bayer Sanidad Animal
Agrovet
Veterinary Anthrax Vaccines Segment by Type
Cell Free PA Vaccines
Live Vaccines
Veterinary Anthrax Vaccines Segment by Application
Cow
Sheep
Swine
Other
Veterinary Anthrax Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anthrax Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anthrax Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anthrax Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary Anthrax Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell Free PA Vaccines
- Live Vaccines
Applications
- Cow
- Sheep
- Swine
- Other
Companies covered
- JOVAC
- Intervac (PVT) Ltd
- Institute for Biological Products
- Indian Immunologicals Limited
- Empresa Colombiana de Productos Veterinarios S.A
- Colorado Serum Company
- Ceva Sante Animale
- Centro Diagnostico Veterinario
- Central Veterinary Control and Research Institute
- Botswana Vaccine Institute
- Biogenesis Bago SA
- Bayer Sanidad Animal
- Agrovet
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Anthrax Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cell Free PA Vaccines
- 2.2.3 Live Vaccines
- 2.3 Veterinary Anthrax Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cow
- 2.3.3 Sheep
- 2.3.4 Swine
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Veterinary Anthrax Vaccines Breakdown Data by Type
- 3.1 Global Veterinary Anthrax Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary Anthrax Vaccines Forecasted Market Size by Type (2027-2032)
4 Veterinary Anthrax Vaccines Breakdown Data by Application
- 4.1 Global Veterinary Anthrax Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary Anthrax Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary Anthrax Vaccines Market Perspective (2021-2032)
- 5.2 Global Veterinary Anthrax Vaccines Growth Trends by Region
- 5.2.1 Global Veterinary Anthrax Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary Anthrax Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary Anthrax Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary Anthrax Vaccines Market Dynamics
- 5.3.1 Veterinary Anthrax Vaccines Industry Trends
- 5.3.2 Veterinary Anthrax Vaccines Market Drivers
- 5.3.3 Veterinary Anthrax Vaccines Market Challenges
- 5.3.4 Veterinary Anthrax Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary Anthrax Vaccines Players by Revenue
- 6.1.1 Global Top Veterinary Anthrax Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary Anthrax Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary Anthrax Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary Anthrax Vaccines Head Office and Area Served
- 6.4 Global Veterinary Anthrax Vaccines Players, Product Type & Application
- 6.5 Global Veterinary Anthrax Vaccines Manufacturers Established Date
- 6.6 Global Veterinary Anthrax Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary Anthrax Vaccines Market Size (2021-2032)
- 7.2 North America Veterinary Anthrax Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary Anthrax Vaccines Market Size by Country (2021-2026)
- 7.4 North America Veterinary Anthrax Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary Anthrax Vaccines Market Size (2021-2032)
- 8.2 Europe Veterinary Anthrax Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary Anthrax Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Veterinary Anthrax Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Anthrax Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary Anthrax Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary Anthrax Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary Anthrax Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary Anthrax Vaccines Market Size (2021-2032)
- 10.2 South America Veterinary Anthrax Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary Anthrax Vaccines Market Size by Country (2021-2026)
- 10.4 South America Veterinary Anthrax Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Anthrax Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary Anthrax Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary Anthrax Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary Anthrax Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 JOVAC
- 12.1.1 JOVAC Company Information
- 12.1.2 JOVAC Business Overview
- 12.1.3 JOVAC Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.1.4 JOVAC Veterinary Anthrax Vaccines Product Portfolio
- 12.1.5 JOVAC Recent Developments
- 12.2 Intervac (PVT) Ltd
- 12.2.1 Intervac (PVT) Ltd Company Information
- 12.2.2 Intervac (PVT) Ltd Business Overview
- 12.2.3 Intervac (PVT) Ltd Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.2.4 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio
- 12.2.5 Intervac (PVT) Ltd Recent Developments
- 12.3 Institute for Biological Products
- 12.3.1 Institute for Biological Products Company Information
- 12.3.2 Institute for Biological Products Business Overview
- 12.3.3 Institute for Biological Products Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.3.4 Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio
- 12.3.5 Institute for Biological Products Recent Developments
- 12.4 Indian Immunologicals Limited
- 12.4.1 Indian Immunologicals Limited Company Information
- 12.4.2 Indian Immunologicals Limited Business Overview
- 12.4.3 Indian Immunologicals Limited Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.4.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio
- 12.4.5 Indian Immunologicals Limited Recent Developments
- 12.5 Empresa Colombiana de Productos Veterinarios S.A
- 12.5.1 Empresa Colombiana de Productos Veterinarios S.A Company Information
- 12.5.2 Empresa Colombiana de Productos Veterinarios S.A Business Overview
- 12.5.3 Empresa Colombiana de Productos Veterinarios S.A Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.5.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio
- 12.5.5 Empresa Colombiana de Productos Veterinarios S.A Recent Developments
- 12.6 Colorado Serum Company
- 12.6.1 Colorado Serum Company Company Information
- 12.6.2 Colorado Serum Company Business Overview
- 12.6.3 Colorado Serum Company Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.6.4 Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio
- 12.6.5 Colorado Serum Company Recent Developments
- 12.7 Ceva Sante Animale
- 12.7.1 Ceva Sante Animale Company Information
- 12.7.2 Ceva Sante Animale Business Overview
- 12.7.3 Ceva Sante Animale Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio
- 12.7.5 Ceva Sante Animale Recent Developments
- 12.8 Centro Diagnostico Veterinario
- 12.8.1 Centro Diagnostico Veterinario Company Information
- 12.8.2 Centro Diagnostico Veterinario Business Overview
- 12.8.3 Centro Diagnostico Veterinario Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.8.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio
- 12.8.5 Centro Diagnostico Veterinario Recent Developments
- 12.9 Central Veterinary Control and Research Institute
- 12.9.1 Central Veterinary Control and Research Institute Company Information
- 12.9.2 Central Veterinary Control and Research Institute Business Overview
- 12.9.3 Central Veterinary Control and Research Institute Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.9.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio
- 12.9.5 Central Veterinary Control and Research Institute Recent Developments
- 12.10 Botswana Vaccine Institute
- 12.10.1 Botswana Vaccine Institute Company Information
- 12.10.2 Botswana Vaccine Institute Business Overview
- 12.10.3 Botswana Vaccine Institute Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.10.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio
- 12.10.5 Botswana Vaccine Institute Recent Developments
- 12.11 Biogenesis Bago SA
- 12.11.1 Biogenesis Bago SA Company Information
- 12.11.2 Biogenesis Bago SA Business Overview
- 12.11.3 Biogenesis Bago SA Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.11.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio
- 12.11.5 Biogenesis Bago SA Recent Developments
- 12.12 Bayer Sanidad Animal
- 12.12.1 Bayer Sanidad Animal Company Information
- 12.12.2 Bayer Sanidad Animal Business Overview
- 12.12.3 Bayer Sanidad Animal Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.12.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio
- 12.12.5 Bayer Sanidad Animal Recent Developments
- 12.13 Agrovet
- 12.13.1 Agrovet Company Information
- 12.13.2 Agrovet Business Overview
- 12.13.3 Agrovet Revenue in Veterinary Anthrax Vaccines Business (2021-2026)
- 12.13.4 Agrovet Veterinary Anthrax Vaccines Product Portfolio
- 12.13.5 Agrovet Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst